Cypriot start-up develops AI tool for cancer treatment
A Cypriot research and innovation team has developed an AI-powered oncology software platform called Prognostic. Supported by the non-profit organization Cyprus Seeds, the project is led by Dr. Chrysovalantis Voutouri as founder, CEO and research director, supported by Professor Triantafyllos Stylianopoulos. The platform aims to enable personalized cancer treatments.